Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Padrão NA"'
Autor:
Pauletto E; Institute of Biological and Chemical Systems-Biological Information Processing, Karlsruhe Institute of Technology, PO-Box 3640, 76021 Karlsruhe, Germany., Eickhoff N; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Padrão NA; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Blattner C; Institute of Biological and Chemical Systems-Biological Information Processing, Karlsruhe Institute of Technology, PO-Box 3640, 76021 Karlsruhe, Germany., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Publikováno v:
Cells [Cells] 2021 Jun 16; Vol. 10 (6). Date of Electronic Publication: 2021 Jun 16.
Autor:
Pereira MS; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Institute of Biomedical Sciences of Abel Salazar, University of Porto Porto, Portugal., Alves I; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Medical Faculty, University of Porto Porto, Portugal., Vicente M; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Institute of Biomedical Sciences of Abel Salazar, University of Porto Porto, Portugal., Campar A; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Institute of Biomedical Sciences of Abel Salazar, University of Porto Porto, Portugal.; Centro Hospitalar do Porto Porto, Portugal., Silva MC; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal., Padrão NA; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Medical Faculty, University of Porto Porto, Portugal., Pinto V; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal., Fernandes Â; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal., Dias AM; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal., Pinho SS; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto, Portugal.; Institute for Research and Innovation in Health (I3S) Porto, Portugal.; Medical Faculty, University of Porto Porto, Portugal.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Nov 27; Vol. 9, pp. 2754. Date of Electronic Publication: 2018 Nov 27 (Print Publication: 2018).
Autor:
Dias AM; Institute for Research and Innovation in Health (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Porto, Portugal., Pereira MS; Institute for Research and Innovation in Health (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Porto, Portugal., Padrão NA; Institute for Research and Innovation in Health (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Medical Faculty, University of Porto, Porto, Portugal., Alves I; Institute for Research and Innovation in Health (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Medical Faculty, University of Porto, Porto, Portugal., Marcos-Pinto R; Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Porto, Portugal; Department of Gastroenterology, Centro Hospitalar do Porto, Porto, Portugal; Medical Faculty, Centre for Research in Health Technologies and Information Systems (CINTESIS), Porto, Portugal., Lago P; Department of Gastroenterology, Centro Hospitalar do Porto, Porto, Portugal., Pinho SS; Institute for Research and Innovation in Health (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Medical Faculty, University of Porto, Porto, Portugal. Electronic address: salomep@ipatimup.pt.
Publikováno v:
Cellular immunology [Cell Immunol] 2018 Nov; Vol. 333, pp. 9-18. Date of Electronic Publication: 2018 Jul 18.
Autor:
Padrão NA; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Monteiro-Reis S; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Torres-Ferreira J; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Antunes L; Department of Epidemiology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Leça L; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Montezuma D; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Ramalho-Carvalho J; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Dias PC; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Monteiro P; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Oliveira J; Department of Urology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal., Henrique R; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS) - University of Porto, Rua de Jorge Viterbo Ferreira n.º 228, Porto 4050-313, Portugal., Jerónimo C; Cancer Biology and Epigenetics Group - Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr António Bernardino de Almeida, Porto 4200-072, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS) - University of Porto, Rua de Jorge Viterbo Ferreira n.º 228, Porto 4050-313, Portugal.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Feb 28; Vol. 116 (5), pp. 634-639. Date of Electronic Publication: 2017 Jan 12.